Enteris specializes in solid oral dose cGMP manufacturing from early clinical trials through phase 3 and commercial supplies.
Enteris has a strong history of quality focus and regulatory compliance, and we follow a client-centric approach to our partnerships. We provide our clients with direct access to our manufacturing team to ensure efficient and optimal manufacturing of clinical and commercial supplies.
Our purpose-built, state of the art cGMP manufacturing facility features over 6,000 square feet of cleanroom space, 2,500 square feet dedicated to HPAPI solid oral dosage manufacturing, and 1,700 square feet of flexible suite space.
- Tablet and mini-tablet compression
- Capsule filling
- HPAPI containment and processing
- Wet and dry granulation
- Aqueous film coating
- Bulk or bottle packaging
Differentiated Manufacturing Expertise:
- Process development
- Process scale-up
- Technology transfer
- Process validation